Neuroone Medical Technologies (NMTC) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Neuroone Medical Technologies (NMTC) over the last 6 years, with Q4 2025 value amounting to -$0.03.
- Neuroone Medical Technologies' EPS (Weighted Average and Diluted) fell 15000.0% to -$0.03 in Q4 2025 from the same period last year, while for Dec 2025 it was -$0.17, marking a year-over-year increase of 3461.54%. This contributed to the annual value of -$0.09 for FY2025, which is 8048.02% up from last year.
- Per Neuroone Medical Technologies' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.03 for Q4 2025, which was down 15000.0% from -$0.04 recorded in Q3 2025.
- Neuroone Medical Technologies' 5-year EPS (Weighted Average and Diluted) high stood at $0.06 for Q4 2024, and its period low was -$0.25 during Q3 2021.
- In the last 5 years, Neuroone Medical Technologies' EPS (Weighted Average and Diluted) had a median value of -$0.13 in 2023 and averaged -$0.13.
- As far as peak fluctuations go, Neuroone Medical Technologies' EPS (Weighted Average and Diluted) surged by 14285.71% in 2024, and later tumbled by 15000.0% in 2025.
- Neuroone Medical Technologies' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.18 in 2021, then surged by 41.41% to -$0.11 in 2022, then crashed by 31.14% to -$0.14 in 2023, then surged by 142.86% to $0.06 in 2024, then plummeted by 150.0% to -$0.03 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.03 in Q4 2025, compared to -$0.04 in Q3 2025 and -$0.03 in Q2 2025.